JS

Jingzi Sherman

VP, Medical and Scientific Affairs at Selux Diagnostics

Jingzi Sherman has extensive experience in the medical and scientific affairs field. Jingzi began their career in 2011 as a Senior Medical Affairs Manager at Roche, where they were responsible for the entire study strategy for the business area(s) and facilitated and developed relationships with the medical/scientific community. Jingzi also served as a Clinical Science Manager, overseeing global design validation plans and study protocols on complex studies. In 2017, they moved to PerkinElmer, Inc. as the Director of Global Medical and Scientific Affairs, where they managed the global clinical operation and clinical strategy team, and served as the key clinical representative for products in development at strategic meetings and advisory boards. In 2020, they became the Director of Medical and Scientific Affairs at Nova Biomedical, and in 2021 they moved to Weavr Health as the VP of R&D and Clinical. Jingzi is currently the VP of Medical and Scientific Affairs at Selux Diagnostics, Inc.

Jingzi Sherman studied at the Shanghai Second Medical University, where they obtained a Medical Degree in Medicine. Jingzi also attended the University of California, Davis. In 2011, they obtained the CCRA certification from the ACRP.

Location

Middletown, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Selux Diagnostics

Selux Diagnostics is developing a Next-Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital-acquired infections, and help combat the global antibiotic resistance epidemic.


Industries

Employees

51-200

Links